Disruptive Innovations 2016 : TrialX to Demo Trialspace, Clinical Trials Website Builder with Built-in Recruitment Tracking Tools

06 Sep Disruptive Innovations 2016 : TrialX to Demo Trialspace, Clinical Trials Website Builder with Built-in Recruitment Tracking Tools

Pharma_DPharmUSA_RGB-840x280

 

Every year, many clinical trial innovators come together on the #DPharm platform to exchange, brainstorm ideas, and network. This year, we are very excited to be part of  Disruptive Innovations to Advance Clinical Trials Conference being held at The Fairmont Copley Plaza, Boston, MA on September 20 – 21, 2016. This is our first DPharm conference and we are participating in the Innovative Sources & Solutions panel.

The Innovative Sources & Solutions panel – Track B will focus on innovation by companies to solve problems with clinical trials. Meet TrialX CEO and Co-Founder, Sharib Khan with other panelists such as:

  • Joe Kim – Sr. Advisor, Clinical Development Innovation, Eli Lilly and Company
  • Adam Butler – SVP, Strategic Development and Corporate Marketing, Bracket
  • Solomon Babani – Global VP, Alliance Management, Covance
  • Shree Kalluri  – Founder and CEO, Nimblify
  • Cheryl Johnson – Project Director,  Synteract

We  will demo our recently launched clinical trial website builder for sponsors, CRO’s, patient recruitment agencies and investigators – Trialspace

 

Trialspace-clinical-trial-website-builder.png

 

Trialspace comes with state-of-the-art built-in patient recruitment and referral tracking tools that are easy to use. See how you can launch your clinical trials website in minutes and take the patient recruitment process to the next century. Scheduled for Day 1 -Sept 20, at 2:00pm.

Sharib Khan CEO and Chintan Patel CTO will also be attending the conference that immediately precedes it, Mobile in Clinical Trials, where Dr. Patel will be speaking on ‘No Phone or Patient Left Behind: The First Cross Platform ResearchKit Based Study’, Sep 19th 12 pm.

Look forward to seeing folks there!

No Comments

Post A Comment

Shares
traffic stats